Shortlist by what you need
Start here if you know why you are leaving NetraMark.
Want the closest match?
TriomicsMost similar to NetraMark in what it does, its category and its price.
Visit (opens Triomics in a new tab)Want the best rated?
Tempus AIRated 4.3 out of 5 in our review, against 3.8 for NetraMark.
Visit (opens Tempus AI in a new tab)
At a glance
Green means better than NetraMark, red means worse. Prices are starting prices per month.
| Tool | Our rating | Starts at | Free plan | Best for | Compare |
|---|---|---|---|---|---|
| 3.8 | Not listed | No | NetraAI analyses clinical trial data to optimise trial design - finding optimal dosage, identifying ideal patient populations and increasing effect size. | ||
| 4.0+0.2 | Not listed | No | AI for oncology workflows, supporting clinical trial matching and cancer care decisions. | vs NetraMark | |
| 4.1+0.3 | Not listed | No | Clinical trial simulation platform for predicting patient response to therapies | vs NetraMark | |
| 3.6−0.2 | Not listed | No | Healthcare data platform and analytics delivering AI-powered insights against clinical, financial and operational outcomes. | vs NetraMark | |
| 4.2+0.4 | Not listed | No | Clinical AI for mental health providers, with published evidence behind it. | vs NetraMark | |
| 4.3+0.5 | Not listed | No | Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue | vs NetraMark | |
| 4.2+0.4 | Not listed | No | Digital twins of trial participants that shrink the control arm by about a third. | vs NetraMark | |
| 4.1+0.3 | Not listed | No | Healthcare data platform that generates synthetic patient data for privacy-safe research and analytics. | vs NetraMark | |
| 4.0+0.2 | Not listed | No | Finds a patient's insurance from minimal detail and verifies eligibility in about six seconds. | vs NetraMark |
The alternatives in detail
In order of how closely each one matches NetraMark.

Triomics
4.0Not listed
vs NetraMark+0.2
AI for oncology workflows, supporting clinical trial matching and cancer care decisions.
- AI built specifically for oncology rather than general medicine
- Clinical trial matching against unstructured patient records
- Structuring of oncology data for downstream decision support
Trial matching addresses a real and higher-priced manual bottleneck
Clinical deployment requires validation and governance review

QuantHealth
4.1Not listed
vs NetraMark+0.3
Clinical trial simulation platform for predicting patient response to therapies.
- In-silico simulation of clinical trial outcomes
- Patient response prediction across therapy candidates
- Protocol testing before a trial is committed
Tests expensive protocol decisions before commitment
Credibility depends on retrospective validation in the same indication

Health Catalyst
3.6Not listed
vs NetraMark−0.2
Healthcare data platform and analytics delivering AI-powered insights against clinical, financial and operational outcomes.
- Healthcare data platform underpinning analytics
- AI-powered insights across clinical, financial and operational domains
- Outcome-focused engagement model
Outcome framing rather than selling dashboards
No public pricing - enterprise health system sales

Limbic
4.2Not listed
vs NetraMark+0.4
Clinical AI for mental health providers, with published evidence behind it.
- Clinical assessment support
- Built for providers and health plans
- Peer-reviewed evidence published in Nature Medicine
Carries published clinical evidence rather than testimonials
Pricing is not published and there is no individual route in

Tempus AI
4.3Not listed
vs NetraMark+0.5
Publicly traded on Nasdaq, guiding to $1.6 billion in 2026 revenue.
- Machine learning applied to genomic and clinical data for precision treatment matching
- One of the largest connected libraries of clinical and molecular data
- Publicly traded on Nasdaq under the ticker TEM
Publicly reported financials give unusual transparency into scale and growth
Pricing runs through insurance billing and enterprise agreements, not published rates

Unlearn.AI
4.2Not listed
vs NetraMark+0.4
Digital twins of trial participants that shrink the control arm by about a third.
- Digital twins forecasting participant outcomes
- Control arm size reduction of around 33 percent
- Scout for literature and regulatory search
Fewer control participants is an ethical gain as well as a commercial one
No published pricing

MDClone
4.1Not listed
vs NetraMark+0.3
Healthcare data platform that generates synthetic patient data for privacy-safe research and analytics.
- Synthetic patient data generation preserving real statistical patterns
- Self-service query and exploration environment for non-technical analysts
- Real-time access to large-scale healthcare datasets
Synthetic-data approach sidesteps lengthy IRB and de-identification review cycles
No public pricing, with enterprise sales cycles typical of hospital software

Sohar Health
4.0Not listed
vs NetraMark+0.2
Finds a patient's insurance from minimal detail and verifies eligibility in about six seconds.
- Insurance discovery from minimal patient detail
- Real-time eligibility checks at a median six seconds
- In-network and out-of-network confirmation
Discovery removes the intake stall when patients do not know their plan
No published pricing and an 8x ROI figure that is the vendor's own
FAQ
Questions people ask
Is NetraMark free?
NetraMark does not list a free plan. Check its pricing page for current plans.
How did you pick these alternatives?
We match tools on what they do, their category and their price, using the details in our directory. Ratings come from our reviews and reader reviews.
